Stocks · Healthcare · Medical - Instruments & Supplies
Kestra Medical Technologies, Ltd. KMTS
$28.34 +3.32% Close, Oct 5, 2026 · NASDAQ · Market cap $1.61B
Strong growth
Next earnings report: Dec 10, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin widened to -134.5% from -175.9% a year earlier.
- Revenue over the last four quarters was $106.7M, up 60.7% from a year earlier.
- The diluted share count rose 14.2% in a year.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 6, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 14%
- Revenue growth, 3-year CAGRTop 6%
- Revenue growth accelerationTop 30%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 27%
- Gross marginBottom 38%
- Operating marginBottom 27%
- Accruals (lower is better)Top 17%
- Interest coverBottom 28%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 47%
- Free-cash-flow yieldBottom 43%
- EBITDA / enterprise valueBottom 41%
- Sales / enterprise valueBottom 24%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 38%
- 6-month returnTop 23%
- 1-year return vs S&P 500Top 46%
- Distance from 52-week highTop 10%
- Trend checklist (0–4)Top 10%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 28%
- Consecutive EPS beatsBottom 20%
- Share of analysts rating BuyBottom 47%
- Upside to consensus price targetBottom 18%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 47%
- Maximum drawdown, 3 yearsTop 17%
- Beta vs S&P 500 (lower is better)Bottom 40%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 59.0% | 60.7% | ↑ |
| Gross margin | 43.5% | 53.9% | ↑ |
| Operating margin | -175.9% | -134.5% | ↑ |
| FCF margin | -167.3% | -115.0% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 60.7% | 59.0% | ↑ | Top 14% |
| Gross margin | 53.9% | 43.5% | ↑ | Bottom 38% |
| Operating margin | -134.5% | -175.9% | ↑ | Bottom 27% |
| Net margin | -140.4% | -180.3% | ↑ | — |
| Free-cash-flow margin | -115.0% | -167.3% | ↑ | — |
| Return on invested capital | -48.0% | — | Bottom 27% | |
| Revenue growth, 3-year CAGR | 131.9% | — | Top 6% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -17.9%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 26.5%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +5.9 pp
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -19.0×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -9.42%
- Shareholder yield
- -9.42%
- Share count change, 1 year
- +14.2%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jul 31, 2026 (filed Sep 14, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 1 of 7
- Average EPS surprise, last 4
- -10.3%
- Average 2-day reaction, last 8
- +2.7%
- Positive 20 days after report
- 3 of 6
Analysts
- Consensus price target
- $30.67
- Target vs current price
- +8.2%
- Analysts with a rating
- 4
- Share rating Buy or Strong Buy
- 75%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Sep 14, 2026 | -21.8% | +5.3% | +6.9% | — | — |
| Jul 14, 2026 | -13.6% | -2.3% | -6.1% | +14.5% | — |
| Mar 17, 2026 | -1.7% | +9.8% | +1.7% | +2.5% | +0.9% |
| Dec 11, 2025 | -4.4% | +1.6% | +9.4% | -0.4% | -9.1% |
| Sep 11, 2025 | +30.3% | +1.2% | +30.5% | +31.9% | +34.7% |
| Jul 15, 2025 | -321.0% | +5.6% | +7.8% | -5.1% | +58.1% |
| Apr 14, 2025 | -107.2% | -1.9% | -3.0% | -2.9% | -37.4% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Sep 14, 2026 | -$0.75 | -$0.62 | -21.8% | $31.0M |
| Jul 14, 2026 | -$0.67 | -$0.59 | -13.6% | $28.6M |
| Mar 17, 2026 | -$0.61 | -$0.60 | -1.7% | $24.6M |
| Dec 11, 2025 | -$0.62 | -$0.59 | -4.4% | $22.6M |
| Sep 11, 2025 | -$0.46 | -$0.66 | +30.3% | $19.4M |
| Jul 15, 2025 | -$2.21 | -$0.53 | -321.0% | $17.2M |
| Apr 14, 2025 | -$1.25 | -$0.60 | -107.2% | $15.1M |
| Feb 10, 2025 | -$0.55 | — | — | $14.7M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 15.14× | — | — | Bottom 24% |
| Free-cash-flow yield | -7.64% | — | — | Bottom 43% |
| Earnings yield | -9.42% | — | — | Bottom 47% |
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✓ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 10
- Days above the 200-day average
- 16
- 50-day average slope (20 days)
- +1.5%
- 200-day average slope (20 days)
- +0.1%
- Distance from 50-day average
- +9.5%
- Distance from 200-day average
- +20.1%
- RSI (14)
- 62.1
- Relative volume
- 0.68×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 54.3%
- Volatility vs own 5-year history
- 5th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.28
- Correlation with S&P 500
- 0.28
- Current drawdown from 1-year high
- -0.4%
- Maximum drawdown, 3 years
- -43.7%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Apr 2, 2025 | Aug 6, 2025 | -43.7% | 86 days | 33 days (Sep 23, 2025) |
| Dec 22, 2025 | Apr 10, 2026 | -36.2% | 74 days | 83 days (Aug 10, 2026) |
| Aug 10, 2026 | Sep 11, 2026 | -19.4% | 23 days | 12 days (Sep 29, 2026) |
| Oct 30, 2025 | Dec 2, 2025 | -17.7% | 22 days | 14 days (Dec 22, 2025) |
| Sep 23, 2025 | Oct 10, 2025 | -14.5% | 13 days | 6 days (Oct 20, 2025) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $1.61B
- EPS, diluted (TTM)
- -$2.67
- Revenue (TTM)
- $106.7M
- 52-week range
- $17.34 – $30.00
| FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|
| Revenue | $7.6M | $27.8M | $59.8M | $95.1M |
| Gross profit | -$10.7M | $362,000 | $24.2M | $48.9M |
| Operating income | -$80.4M | -$85.1M | -$106.4M | -$134.7M |
| Net income | -$84.2M | -$94.1M | -$113.8M | -$131.6M |
| EPS (diluted) | -$1.75 | -$2.04 | -$5.13 | -$2.43 |
| Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $14.7M | $15.1M | $17.2M | $19.4M | $22.6M | $24.6M | $28.6M | $31.0M |
| Net income | -$20.4M | -$21.5M | -$52.1M | -$25.8M | -$32.8M | -$34.2M | -$38.8M | -$44.1M |
| EPS (diluted) | -$0.48 | -$0.50 | -$2.21 | -$0.50 | -$0.64 | -$0.61 | -$0.67 | -$0.75 |
| FY 2021 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|
| Operating cash flow | -$29.9M | -$69.6M | -$72.2M | -$77.6M | -$81.7M |
| Capital expenditure | -$336,000 | -$15.5M | -$12.5M | -$23.6M | -$34.9M |
| Free cash flow | -$30.2M | -$85.1M | -$84.7M | -$101.2M | -$116.6M |
| Dividends paid | -$187,000 | $0 | -$799,000 | -$1.7M | -$323,000 |
| Net share buybacks | $0 | $102.1M | $0 | $215.8M | $149.3M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $198.9M
- Total assets
- $347.4M
- Total liabilities
- $125.0M
- Total debt
- $76.4M
- Net debt
- $7.9M
- Shareholders’ equity
- $222.4M
As of Jul 31, 2026 (filed Sep 14, 2026).
Short interest
- Shares sold short
- 3,123,641
- Days to cover
- 8.34
- Change vs previous report
- +5.1%
FINRA short interest, settlement date Sep 15, 2026.